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ultrastructure. The ﬁndings presented in this work may be of great
interest as they suggest that a defect in ATP synthase oligomerization has
strong mitochondrial repercussions. Although it has to be formally
investigated, wemay speculate that ATP synthase oligomerization defect
could be at the origin (or concomitant to) mitochondrial pathologies.
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The biogenesis of eukaryotic mitochondrial ATP synthase (ATPase)
proceeds as modular enzyme assembly from pre-assembled domains.
Discoveries of accessory subunits DAPIT and MLQ, or assembly factors
such as TMEM70 present uniquely in vertebrates suggest that ATPase
biogenesis may show signiﬁcant differences between higher and lower
eukaryotes. Our previous studies in human HEK293 cells showed that
shRNA downregulation of central stalk subunits γ, δ, and ε led to
decreased content of ATPase, which is functionally and structurally
normal. Importantly we did not detect any incomplete ATPase
complexes with proton conductance uncoupled from ATP synthesis,
which occur when these subunits are deleted in yeast. The only
identiﬁed subcomplex in HEK293 with γ, δ, or ε knockdown was an
assembly intermediate or aggregate of subunit c without apparent
association of other ATPase subunits. In the present study we further
explored the composition of the c subcomplex. We overexpressed
subunit c isoform 1 with C-terminal FLAG tag for simpliﬁed detection
and isolation in control HEK293, as well as in cells with shRNA
knockdowns of subunits γ, δ, and ε. Native and SDS/PAGE experiments
showed that the overexpressed c subunit can be incorporated into
ATPase holoenzyme. The tagged variant was also detected in the
accumulated subcomplex in knock-down cell lines. The distribution of
tagged subunit c between the holoenzyme and the subcomplex reﬂected
the pattern of the endogenous subunit. Interestingly, a small portion of
the subunit c subcomplex of identical sizewas also found in control cells,
suggesting that it might represent genuine assembly intermediate, and
not only an aberrant complex formed in γ, δ, or ε downregulated cells.
Anti-FLAG antibody immunoprecipitation led to successful pull-out of
both the subunit c subcomplex, and the holoenzyme as evidenced by co-
immunoprecipitation of other ATPase subunits, including the endoge-
nous c subunit. These results indicate the formation of hybrid c-rings
composed of both subunit variants. Mass spectrometric analysis of the
precipitated fraction failed to identify any candidate subunit c chaper-
ones/assembly factors associated with the accumulated subcomplexes.
Our results suggest that in mammalian cells, subunit c rings may be
formed by self-assembly, as previously shown in lower organisms. This
study was supported by Grant Agency of the Czech Republic (P303/12/
1363, 14-368046), and Grant Agency of Charles University (1160214).
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The increasing number of tuberculosis (TB) infections with multi-
drug resistant (MDR)Mycobacterium tuberculosis strains causes a severe
health problem, necessitating the development of new antibiotics (Koul
et al., 2011). A novel antibiotic drug, Bedaquiline (Sirturo™, formerly
TMC207), was found to be highly effective in the treatment of MDR-TB
(Andries et al., 2005). It was reported that it targets the rotor ring of the
energy converting enzyme F1Fo-ATP synthase (Haagsma et al., 2009;
Segala et al., 2012), which is essential for the survival of mycobacteria.
However, structural and biochemical information about the precise
binding site of Bedaquiline and its mechanism of action are not known at
the level of the isolated ATP synthase. We performed ATP synthesis
inhibition experiments using two different antibiotics, Bedaquiline and
Meﬂoquine, which efﬁciently inhibited the synthesis and hydrolytic
activity of a mycobacterial ATP synthase. Furthermore, drug competition
assays with the ATP synthesis inhibitor dicyclohexylcarbodiimide
(DCCD) using the isolated, mycobacterial c-ring showed that Bedaquiline
competes with DCCD at the proton binding site. We present direct
biochemical proof that the c-ring's ion binding site is the actual target of
the drug; the binding is highly speciﬁc and has a high afﬁnitywith a Kd in
the nanomolar range. To further explore the molecular basis of the
interaction we performed isothermal titration calorimetry (ITC) using
WT andmutant c-rings, which providing a list of residues involved in the
interaction. Finally we also aim to solve the structure of the c-ring in
complex with Bedaquiline using X-ray crystallography. 3D crystals of the
c-ring/Bedaquiline complex and their X-ray diffracting power are
presented. References: Andries K et al., (2005) A diarylquinoline drug
active on the ATP synthase of Mycobacterium tuberculosis. Science 307:
223–227 Haagsma AC et al., (2009) Selectivity of TMC207 towards
mycobacterial ATP synthase compared with that towards the eukaryotic
homologue. Antimicrobial agents and chemotherapy 53: 1290–1292
Koul A et al., (2011) The challenge of newdrug discovery for tuberculosis.
Nature 469: 483–490 Segala E et al., (2012) New mutations in the
mycobacterial ATP synthase: new insights into the binding of the
diarylquinoline TMC207 to the ATP synthase C-ring structure. Antimi-
crobial agents and chemotherapy 56: 2326–2334.
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F-type ATP synthase (FoF1) is the rotary motor protein that
mediates the energy conversion between phosphate transfer poten-
tial of ATP and proton motive force (pmf) across biomembranes via
mechanical rotation of the inner rotor complex. To understand the
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